Shandong Xinhua Pharmaceutical Company Limited (XIN) — Strategic Asset Allocation Index
Shandong Xinhua Pharmaceutical Company Limited (XIN) has a Strategic Asset Allocation Index of 84.9% as of September 2023. Strategic assets (PP&E of €3.99 Billion plus long-term investments of €-) total €3.99 Billion, measured against net assets of €4.70 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Shandong Xinhua Pharmaceutical Company L liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Shandong Xinhua Pharmaceutical Company Limited Strategic Asset Allocation Index (2013–2022)
This chart shows how Shandong Xinhua Pharmaceutical Company Limited's Strategic Asset Allocation Index has evolved across 10 annual periods from 2013 to 2022. As of September 2023, the index stands at 84.9%, representing strategic assets of €3.99 Billion against net assets of €4.70 Billion EUR. See financial agility of Shandong Xinhua Pharmaceutical Company L to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Shandong Xinhua Pharmaceutical Company Limited (2013–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Shandong Xinhua Pharmaceutical Company Limited from 2013 to 2022, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see XIN market cap overview.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 92.0% | €4.00 Billion | €4.00 Billion | €- | €4.35 Billion | ▼ -11.2 pp |
| 2021 | 103.1% | €3.77 Billion | €3.77 Billion | €- | €3.65 Billion | ▼ -1.2 pp |
| 2020 | 104.4% | €3.54 Billion | €3.54 Billion | €- | €3.39 Billion | ▼ -8.1 pp |
| 2019 | 112.4% | €3.50 Billion | €3.20 Billion | €296.25 Million | €3.11 Billion | ▲ +1.9 pp |
| 2018 | 110.6% | €3.09 Billion | €2.90 Billion | €189.74 Million | €2.80 Billion | ▲ +0.2 pp |
| 2017 | 110.3% | €2.85 Billion | €2.59 Billion | €258.14 Million | €2.58 Billion | ▼ -14.0 pp |
| 2016 | 124.3% | €2.58 Billion | €2.40 Billion | €189.47 Million | €2.08 Billion | ▲ +2.0 pp |
| 2015 | 122.3% | €2.43 Billion | €2.23 Billion | €200.43 Million | €1.98 Billion | ▼ -1.9 pp |
| 2014 | 124.2% | €2.37 Billion | €2.15 Billion | €220.59 Million | €1.91 Billion | ▲ +11.6 pp |
| 2013 | 112.5% | €2.12 Billion | €1.99 Billion | €127.41 Million | €1.88 Billion | — |